SCHEDULE: Wells Fargo Discloses 5.1% Stake in Cosmos Health

Wells Fargo & Company has reported beneficial ownership of 5.1% of Cosmos Health Inc.'s common stock as of September 30, 2026.

Summary

• Wells Fargo & Company, through its subsidiaries Wells Fargo Advisors Financial Network, LLC and Wells Fargo Clearing Services, LLC, has filed a Schedule 13G.
• The filing indicates beneficial ownership of 5,119,640 shares of Cosmos Health Inc. common stock.
• This represents 5.1% of the class of securities.
• The date of the event requiring this filing was September 30, 2026.
• Wells Fargo & Company is classified as a Broker or dealer registered under section 15 of the Act.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new information about the company's operations or future prospects.

Positives

• Wells Fargo & Company, a significant financial institution, has taken a notable stake in Cosmos Health Inc., which could be interpreted as a sign of confidence in the company's potential by a major market player.

Negatives

• The filing is a standard disclosure and does not provide any new operational or financial performance data for Cosmos Health Inc., leaving its current business standing unaddressed.
• The information is limited to ownership and does not offer insights into the strategic intentions behind Wells Fargo's stake.

Risks

• The filing does not explicitly mention any risks associated with Cosmos Health Inc.'s business operations or financial health.
• Potential risks could arise if Wells Fargo's investment strategy changes, leading to a significant sell-off of shares.

Future Outlook

No forward-looking statements or guidance regarding Cosmos Health Inc.'s future performance are provided in this filing.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors like Wells Fargo when they acquire a significant stake (typically 5% or more) in a public company. This filing indicates a passive investment approach, as opposed to a Schedule 13D which suggests a more active or controlling interest.

Stakeholder Impact

• Shareholders of Cosmos Health Inc. may see the increased institutional ownership by Wells Fargo as a positive signal, potentially influencing investor sentiment.
• The filing does not directly impact employees, customers, suppliers, or creditors of Cosmos Health Inc. beyond the general market perception of the company.

Next Steps

• Wells Fargo & Company will continue to hold its shares in Cosmos Health Inc. in the ordinary course of business.
• Future filings may be required if ownership levels change significantly.

Key Dates

Keywords

Wells Fargo, Cosmos Health, Schedule 13G, Beneficial Ownership, Broker-Dealer, Securities Ownership